Fundz

Ajax Therapeutics, Inc. reported raising $37.4 Million in an initial SEC Form D filing, from an offering of $40 Million

PRIVATEJun 01, 2021$37.4M of $40M raised

Amount Raised

$37.4 Million

$37.4 Million sold, per SEC Form D (first sale Jun 1, 2021)

Round Type

Venture

New YorkOtherBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Who to call at Ajax Therapeutics, Inc., and when

A new round usually means Ajax Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ajax Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ajax Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ajax Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ajax Therapeutics, Inc.

Location

275 MADISON AVE, 39TH FLOOR

New York, New York, United States

About

Ajax Therapeutics, Inc. is pursuing uniquely selective approaches to develop novel next generation therapies for myeloproliferative neoplasms (MPNs), including myelofibrosis. By combining the deep cancer and structural biology insights of our founding scientists with the industry’s most advanced computational drug discovery and protein structure platforms, we aim to discover and develop more precisely designed therapies to address the significant unmet needs for patients with MPNs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ajax Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRoss L., Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ajax Therapeutics, Inc.'s next move

See what Strategic adds

Ajax Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.